Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   Abstract views HTML views PDF downloads Totals
10,412 Dovepress* 5,050 2,468+ 1,490 7,518
PubMed Central* 0 2,894 954 2,894
Totals 5,050 5,362 2,444 10,412
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 4 6

View citations on PubMed Central and Google Scholar